INVE-B Stock Analysis: Investor ser. | ST
Asset Management | ST, Sweden | Market Cap: 1.226.484m SEK | 12M Return: 42% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 919M
EPS Trend: 0.0%
Rev. Trend: 5.5%
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Investor AB (publ) is a Stockholm-based private equity firm founded in 1916 that operates through two principal business lines: core investments in listed companies and operating investments focused on medium-sized to large Northern European businesses. The firm invests globally across health care, financial services, IT, fintech, life sciences, data, materials science, AI, and quantum technology, with core investments also spanning listed minority positions.
For operating investments, Investor AB typically deploys between $200 million and $700 million per transaction, taking either majority or influential minority stakes, and prefers to secure board representation in portfolio companies. The firm targets a holding period of three to seven years before exiting its private equity positions, while its financial investments are held for shorter horizons as minority financial holdings.
As a Swedish investment company with a dual-class share structure, Investor ABs B-shares offer lower voting rights compared to its A-shares, a structure historically associated with the Wallenberg familys controlling influence. Listed in the Industrials sector under Environmental & Facilities Services within the GICS classification, the company functions as a perpetual-capital investment vehicle, distinguishing it from traditional private equity funds that have fixed lifespans.
- Atlas Copco and ABB drive listed holdings valuation gains
- Mölnlycke Health Care margins pressured by raw material costs
- Discount to NAV narrows as Swedish equity sentiment improves
| Net Income: 263b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.34 > 1.0 |
| NWC/Revenue: 7.72% < 20% (prev 45.94%; Δ -38.22% < -1%) |
| CFO/TA 0.02 > 3% & CFO 23.9b > Net Income 263b |
| Net Debt (106b) to EBITDA (267b): 0.40 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.07b) vs 12m ago 0.03% < -2% |
| Gross Margin: 93.46% > 18% (prev 91.69%; Δ 1.77% > 0.5%) |
| Asset Turnover: 27.58% > 50% (prev 8.76%; Δ 18.82% > 0%) |
| Interest Coverage Ratio: 48.85 > 6 (EBIT TTM 267b / Interest Expense TTM 5.46b) |
| A: 0.02 (Total Current Assets 43.5b - Total Current Liabilities 19.7b) / Total Assets 1249b |
| B: 0.74 (Retained Earnings 925b / Total Assets 1249b) |
| C: 0.24 (EBIT TTM 267b / Avg Total Assets 1117b) |
| D: 6.65 (Book Value of Equity 1086b / Total Liabilities 163b) |
| Altman-Z'' = 11.13 = AAA |
| DSRI: 3.0 (Receivables 12.5b/3.00m, Revenue 308b/86.3b) |
| GMI: 0.98 (GM 91.69% / 93.46%) |
| AQI: 1.03 (AQ_t 0.95 / AQ_t-1 0.92) |
| SGI: 3.57 (Revenue 308b / 86.3b) |
| TATA: 0.19 (NI 263b - CFO 23.9b) / TA 1249b) |
| Beneish M = 0.48 (Cap -4..+1) = D |
As of July 28, 2026, the stock is trading at SEK 406.70 with a total of 2,781,763 shares traded. Over the past week, the price has changed by +2.30%, over one month by +2.44%, over three months by +10.43% and over the past year by +41.95%.
Current recommended Stop Loss: 397.70 (which is 2.2% or 1.4 ATR below the current price).
Investor ser. has no consensus analysts rating.
P/E Trailing = 4.7083
P/E Forward = 3.7707
P/S = 3.7685
P/B = 1.1237
P/EG = 5.0848
Revenue TTM = 308b SEK
EBIT TTM = 267b SEK
EBITDA TTM = 267b SEK
Long Term Debt = 111b SEK (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b SEK (from shortTermDebt, last quarter)
Debt = 126b SEK (from shortLongTermDebtTotal, last quarter) + Leases 128.0m
Net Debt = 106b SEK (calculated: Debt 126b - CCE 19.5b)
Enterprise Value = 1333b SEK (1226b + Debt 126b - CCE 19.5b)
Interest Coverage Ratio = 48.85 (Ebit TTM 267b / Interest Expense TTM 5.46b)
EV/FCF = 64.44x (Enterprise Value 1333b / FCF TTM 20.7b)
FCF Yield = 1.55% (FCF TTM 20.7b / Enterprise Value 1333b)
FCF Margin = 6.71% (FCF TTM 20.7b / Revenue TTM 308b)
Net Margin = 85.22% (Net Income TTM 263b / Revenue TTM 308b)
Gross Margin = 93.46% ((Revenue TTM 308b - Cost of Revenue TTM 20.2b) / Revenue TTM)
Gross Margin QoQ = none% (prev 67.33%)
Tobins Q-Ratio = 1.07 (Enterprise Value 1333b / Total Assets 1249b)
Interest Expense / Debt = 4.33% (Interest Expense 5.46b / Debt 126b)
Taxrate = 0.46% (1.22b / 264b)
NOPAT = 265b (EBIT 267b * (1 - 0.46%))
Current Ratio = 2.21 (Total Current Assets 43.5b / Total Current Liabilities 19.7b)
Debt / Equity = 0.12 (Debt 126b / totalStockholderEquity, last quarter 1086b)
Debt / EBITDA = 0.40 (Net Debt 106b / EBITDA 267b)
Debt / FCF = 5.15 (Net Debt 106b / FCF TTM 20.7b)
Total Stockholder Equity = 981b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.51% (Net Income 263b / Total Assets 1249b)
RoE = 26.77% (Net Income TTM 263b / Total Stockholder Equity 981b)
RoCE = 24.42% (EBIT 267b / Capital Employed (Equity 981b + L.T.Debt 111b))
RoIC = 21.84% (NOPAT 265b / Invested Capital 1216b)
WACC = 7.65% (E(1226b)/V(1352b) * Re(7.99%) + D(126b)/V(1352b) * Rd(4.33%) * (1-Tc(0.00)))
Discount Rate = 7.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 46.81 | Cagr: 0.01%
[DCF] Terminal Value 76.09% ; FCFF base≈20.3b ; Y1≈21.2b ; Y5≈24.4b
[DCF] Fair Price = 148.9 (EV 377b - Net Debt 106b = Equity 270b / Shares 1.82b; r=8.35% [WACC [floored]]; 5y FCF grow 5.12% → 2.50% )
EPS Correlation: 0.02 | EPS CAGR: 0.02% | SUE: N/A | # QB: 0
Revenue Correlation: 5.49 | Revenue CAGR: 2.33% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=48.45 | Chg30d=+20.75% | Revisions=+25% | GrowthEPS=-5.7% | GrowthRev=+5.1%
EPS next Year (2027-12-31): EPS=26.99 | Chg30d=+5.50% | Revisions=-25% | GrowthEPS=-44.3% | GrowthRev=+0.5%